Billing and Coding: MolDX: Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy (ARVD/C) Testing

Molecular genetic panel testing for ARVD/C (genes RYR2, TMEM43, DSP, PKP2, DSG2, DSC2, JUP) is statutorily excluded and therefore not covered for any indication, including diagnostic confirmation or family cascade testing. Claims for excluded ARVD/C testing should be submitted with modifier GY (use GX if a voluntary ABN was issued) and must include the appropriate diagnosis and the DEX Z-Code™ identifier adjacent to the CPT code in the specified claim fields for Part A and Part B submissions.

"Molecular genetic testing for Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy (ARVD/C) involving genes RYR2, TMEM43, DSP, PKP2, DSG2, DSC2, and JUP is statutorily excluded and is not cove..."

Sign up to see full coverage criteria, indications, and limitations.